Solid Tumor Testing Market Trends That Will Shape the Next Decade: Insights from Innovative Liquid Biopsy Tests Drive Solid Tumor Testing Market Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Solid Tumor Testing Market Size By 2025?
The market size for solid tumor testing has experienced significant growth in the last few years. The market is expected to increase from $27.96 billion in 2024 to $30 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The historical growth can be linked to factors such as precision medicine, inadequate tumor-specific drug delivery, low effectiveness of therapy, unmanageable expenses, and simplistic strategies towards cancer chemotherapies.

How Big Is the Solid Tumor Testing Market Size Expected to Grow by 2029?
The market size for solid tumor testing is forecasted to experience a robust expansion in the approaching years, rising to a worth of $40.06 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. The expected growth in the forecasting period could be due to the rising instances of cancer, improved healthcare infrastructure, the advent of AI and IoT-based diagnostic devices, as well as increasing governmental initiatives. Notable trends during the same forecasted period comprise advancements in diagnostic tools, the advent of therapies based on nanocarrier, strategical collaborations, and the introduction of next-generation testing devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

Which Key Market Drivers Powering Solid Tumor Testing Market Expansion and Growth?
The solid tumor testing market's growth is anticipated to be driven by the rising incidence of cancer. Cancer is characterized by uncontrolled growth and dispersion of the body's abnormal cells. These anomalous cells, known as cancer cells, have the potential to invade nearby tissues and organs. There is also the possibility of these cancer cells spreading to other body parts via the bloodstream or lymphatic system. Approximately 90% of cancers in adults are solid tumors. Solid tumor testing is utilized to identify cancer cells in the blood of patients with solid tumors, even when the cancer is not detectable through imaging tests. For example, the Centers for Disease Control and Prevention, a US-based national public health agency, reported in June 2023 that there were 1,603,844 new cases of cancer and 602,347 cancer-related deaths in the US in 2020. Additionally, 403 new cases of cancer and 144 cancer-related deaths were reported per 100,000 individuals. Consequently, the increasing incidence of cancer is fueling the expansion of the solid tumor testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12658&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Solid Tumor Testing Market?
A key trend gaining traction in the solid tumor testing market is the development of novel liquid biopsy test solutions. Firms are striving to strengthen their market position and create a competitive edge by focusing on the development of these groundbreaking liquid biopsy test solutions. NeoGenomics Inc., a US-based testing laboratory organization, for example, unveiled a complete set of three liquid biopsy tests for cancer patients in June 2020. The cutting-edge tests are designed to discover cancer cells in the blood of patients with solid tumors, even if the cancer has not yet been detected through imaging tests. These tests can aid doctors in deciding on additional testing or treatment courses. Not only is it non-invasive, but it also offers early detection, custom treatment, and is FDA-approved. What's more, all three new tests promise a turnaround time of seven days or less, saving significant time for clinicians.

What Are the Emerging Segments in the Solid Tumor Testing Market?
The solid tumor testing market covered in this report is segmented -

1) By Type: Genetic Testing, Conventional Testing
2) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer
3) By Application: Clinical, Research
4) By End-Users: Hospitals, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutions

Subsegments:
1) By Genetic Testing: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH)
2) By Conventional Testing: Histopathology, Cytology, Imaging Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12658&type=smp

Who Are the Global Leaders in the Solid Tumor Testing Market?
Major companies operating in the solid tumor testing market include Johnson & Johnson Ltd, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Molecular Inc., Becton Dickinson And Company (BD), Quest Diagnostics Incorporated, Tosoh Corporation, Agilent Technologies Inc., bioMerieux Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Miltenyi Biotec GmbH, Natera Inc., Myriad Genetics Inc., Novocure Inc., Invitae Corporation, Guardant Health Inc., Foundation Medicine Inc., Epic Sciences Inc., Biocare Medical LLC, Agena Bioscience Inc., Caris Life Sciences Inc., 20/20 Gene Systems Inc., Grail Inc., Avant Diagnostics Inc., Genomic Testing Cooperative, Eutropics Pharmaceuticals Inc., Anixa Biosciences Inc., Cellular Biomedicine Group.

Which are the Top Profitable Regional Markets for the Solid Tumor Testing Industry?
North America was the largest region in the solid tumor testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the solid tumor testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12658

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.